About Cigna Group
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.thecignagroup.com/
Frequently Asked Questions
What is the 52-week range for CI?
The 52-week high is $315.47 and the 52-week low is $239.51.
What is the P/E ratio for CI?
The Price to Earnings (P/E) ratio is 11.01.
What is the dividend yield for CI?
The indicated annual dividend yield is 1.74%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 15.24%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 2.27%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.76.
Analyst Recommendation Trends
Wall Street analyst consensus for CI over the last few months:
Latest CI News
How Much Downside Is Left In CVS Health Stock?
CVS Health (CVS) stock lost 12.7% in the past month without company news, and peers UnitedHealth, Cigna and Elevance Health fell too. The S&P 500 rose 0.6% over the same month. The shares now trade 22.5% below their 52-week high. How much further could CVS stock fall if the market itself turns down.
Cigna Better Positioned to Meet Long-Term EPS Growth Targets, RBC Says
Cigna (CI) is better positioned to achieve its long-term earnings-per-share growth goals, RBC Capita
RBC Capital Reiterates Outperform on Cigna Group, Maintains $337 Price Target
RBC Capital analyst Ben Hendrix reiterates Cigna Group (NYSE:CI) with a Outperform and maintains $337 price target.
Cigna: Deeply Undervalued With Expected Double-Digit EPS Growth Ahead
Cigna is rated a 'Strong Buy' for its compelling value, robust earnings growth, and capital returns at a forward P/E of 8.9x. Learn more about CI stock here.
The Cigna Group (CI) Analyst/Investor Day Transcript
The Cigna Group (CI) Analyst/Investor Day September 30, 2026 8:30 AM EDTCompany ParticipantsRalph Giacobbe - Senior Vice President of Investor...
Cigna Group (CI), What Is Behind The Fresh Attention?
Cigna Group (CI) used its 2026 Investor Day to roll out a new Lead to One vision, outline a US$3b modernization push, and reaffirm both current guidance and long term growth targets. Cigna Group’s recent Investor Day comes after a period where momentum has cooled, with the share price at US$271.83 and a 90 day share price return down 5.5%, while the 5 year total shareholder return of 46.8% points to a much stronger longer run outcome. Compare Cigna Group’s new long term plan with peers by...
Cigna Reaffirms 2026 Outlook, Targets Complex Care and AI-Driven Growth
Cigna Group (NYSE:CI) reaffirmed its 2026 outlook and outlined a long-term strategy centered on complex care, technology-enabled personalization and disciplined capital deployment at its 2026 Investor Day. President and CEO Brian Evanko said the company has reshaped its portfolio over the past deca
Cigna (CI) Stock Looks Reasonable Against Its Earnings Power
Cigna Group has delivered a mixed run in recent years, and investors now have to decide whether the current US$275.26 share price lines up with what its earnings justify. The question is whether that price fairly reflects what the business is generating today, rather than just where the stock has traded before. Over the past 5 years the stock has gained about 50.0%, which puts real weight on whether the underlying earnings profile can support that kind of long term outcome. The business...
Cigna Investor Day Spotlights Specialty Drugs
Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.
Cigna Sets Long-Term Goals, Unveils 2030 Modernization Strategy
Cigna unveils its Lead to One vision, reaffirms 2026 financial targets, and sets a $3 billion modernization plan.
Wednesday's session: gap up and gap down stock in the S&P500 index
Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.
Will New CEO’s Specialty Pharmacy Focus Reshape Cigna Group’s (CI) Evernorth and Signature Narrative?
Recently, investors focused on Cigna Group’s leadership change as new CEO Brian Evanko began outlining plans for the company’s specialty pharmacy business. This leadership shift matters because specialty pharmacy is a core earnings engine, and any change in its direction could reshape Cigna’s long‑term mix of health services. Next, we’ll examine how Evanko’s emphasis on specialty pharmacy growth could influence Cigna Group’s existing investment narrative around Evernorth and Signature. AI is...
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will
The Cigna Group (CI) Analyst/Investor Day - Slideshow
2026-09-30. The following slide deck was published by The Cigna Group in conjunction with this event.
The Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities
Today, at its Investor Day, The Cigna Group (NYSE: CI) will outline its strategy to improve affordability and personalization across the health care continuum. Enterprise leaders will detail how the Company's deliberately shaped portfolio, differentiated leadership in complex care, and disciplined execution position it to deliver durable growth, robust operating cash flow, and enhanced shareholder returns.
Cigna Group Affirms FY2026 Adj EPS Of At Least $30.45 Vs $30.41 Est; Affirms FY2026 Revenue Of ~$280.000B Vs $285.608B Est
Cigna Group (NYSE:CI) FY2026 expected to be at least $30.45 vs $30.41 Est. FY2026 Revenue expected to be ~$280.000B vs $285.608B Est
What Are UNH Stock Investors Betting On?
UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.
Cigna Stock in Focus as Investor Day Spotlights Specialty Drugs
Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.
Cigna Healthcare Expands AI-Enabled Personalized Support To Help More Customers Access Care Earlier, Improve Affordability
https://newsroom.cigna.com/cigna-healthcare-expands-ai-enabled-personalized-support
Mark Cuban Says He’s ‘All for Universal Care’ But Warns It Won’t ‘Automagically Work,’ and the ‘Best First Step’ Is This Warren-Hawley Bill
Cuban believes in Medicare for All, but thinks people need to temper their expectations. He thinks a recently introduced bill is most consumers' best shot for now.
‘That’s Immediate Cash in the Bank’: Billionaire Mark Cuban Says the Quickest Way for a Company to Raise Money Is to Change Its PBM
Mark Cuban offers an unconventional way for employers to raise funding if they need it: Change your PBM.
What Should CVS Stock Investors Be Watching Now?
If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.
2 Profitable Stocks with Solid Fundamentals and 1 We Avoid
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Podcast
By Exec Edge Editorial Staff Health insurance premiums have climbed for years. Deductibles have climbed right along with them. Yet a growing number of American households are choosing neither, opting instead for a decades-old alternative, which is not health insurance, built around monthly contributions and community values. “People are clearly paying high premiums now,” Liberty […] The post Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Pod
Did UnitedHealth Name The Fix Before Its Stock Ran?
UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.
Can UNH Stock Keep Growing Earnings While Its Sales Stall?
UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.
Dividend Champion, Contender, And Challenger Highlights: Week September 20
Track weekly dividend updates for Dividend Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend dates and pay dates here.
Can Cigna's AI Push Help Rein In Rising Healthcare Costs?
CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.
Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?
CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.
The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet
UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.
Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection
New research from The Cigna Group (NYSE: CI) finds that volunteering is associated with better health, stronger workplace engagement, and greater connection to community. According to the company's fifth annual Vitality in America report, people who volunteer are nearly twice as likely to report high vitality, a measure of how healthy, connected, and capable a person feels. The research also found that employees who participate in employer-supported volunteer activities are significantly more li
Is Cigna Group (CI) Still Undervalued Or Are The Risks Keeping It Fairly Priced?
Cigna Group (CI) continues to draw attention after its recent close at US$288.90, with investors weighing modest return figures across the past week, month, and past 3 months against the insurer's broader long term track record. Recent trading has been more mixed for Cigna Group, with the share price slipping 0.4% on the day but still posting a 4.7% 7 day gain and a 3.5% year to date share price return. The 1 year total shareholder return of 0.4% and 5 year total shareholder return of 56.7%...
CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?
The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.
Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?
UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.
Should You Buy Elevance Health Stock For The Margin It Lost?
Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.
Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?
CVS is benefiting from pharmacy growth, AI investments and a discounted valuation, but reimbursement pressure and regulatory scrutiny remain key risks.
BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?
BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.
Why Is UNH Stock Trading At A Premium With The Slowest Growth?
UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.
Cigna Group Executive Neville Everett Sells 617 Shares for $175,000
Everett disposed of 11% of his direct equity holdings under a pre-arranged Rule 10b5-1 trading plan, leaving a stake valued at $1.45 million.
UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation
TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.
Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
The Cigna Group to Host Investor Day on September 30
Global health company The Cigna Group (NYSE: CI) will host its Investor Day on Wednesday, September 30, 2026.
Wall Street Brunch: Make Or Break Inflation For The Fed
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
The GLP-1 Squeeze: How Soaring Healthcare Costs Are Forcing Employers to Act
As employers brace for a fresh round of rising healthcare costs that outpace inflation, the stakes are getting higher for companies to contain spending on treatments such as popular GLP-1 medications for weight loss.
Oracle, Adobe Results In Focus As Earnings Season Winds Down
Stay ahead with Wall Street Week Ahead: key earnings (Oracle, Adobe, Kroger), IPOs & CPI/PPI data, plus volatility/dividend watch. See more here.
UnitedHealth Stock Recovered Before Its Margins Did
UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.
CVS Stock Has Left Its Peers Behind. Or Has It?
The market has crowned this healthcare giant the winner of its group, but a look at the underlying business raises the question of whether the celebration started too soon.
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-03 | Neville Everett | -617 | $284.05 | $175,259 |
| 2026-09-01 | Evanko Brian C | +6,716 | - | - |
| 2026-09-01 | Evanko Brian C | +3,113 | - | - |
| 2026-08-31 | Kurian George | +109 | $276.08 | $30,093 |
| 2026-08-18 | Jones Nicole S | -2,677 | $279.61 | $748,516 |
| 2026-08-06 | Holgerson Bryan | +1 | $275.25 | $275 |
| 2026-08-05 | Jones Nicole S | -1,301 | - | - |
| 2026-08-05 | Jones Nicole S | +1,301 | $192.02 | $249,818 |
| 2026-08-04 | Jones Nicole S | -14,045 | - | - |
| 2026-08-04 | Jones Nicole S | -19,436 | $276.27 | $5,369,584 |
| 2026-08-04 | Jones Nicole S | +14,045 | $192.02 | $2,696,921 |
| 2026-07-23 | Holgerson Bryan | +1 | $286.29 | $286 |
| 2026-07-09 | Holgerson Bryan | +1 | $291.8 | $292 |
| 2026-06-12 | Kates Jamie G | -899 | - | - |
| 2026-06-12 | Kates Jamie G | -899 | $298.612 | $268,452 |
| 2026-06-12 | Kates Jamie G | +899 | $152.8947 | $137,452 |
| 2026-06-01 | Koka Durga Prasad | -729 | $275.53 | $200,861 |
| 2026-05-29 | Kurian George | +108 | $277.4 | $29,959 |
| 2026-05-13 | Cordani David | -7,971 | - | - |
| 2026-05-13 | Cordani David | -15,458 | - | - |
| 2026-05-13 | Cordani David | +7,971 | $197.35 | $1,573,077 |
| 2026-05-13 | Cordani David | +15,458 | $149.135 | $2,305,329 |
| 2026-05-12 | Cordani David | -85,519 | - | - |
| 2026-05-12 | Cordani David | -103,595 | - | - |
| 2026-05-12 | Cordani David | -2,231 | $298.5328 | $666,027 |
| 2026-05-12 | Cordani David | -15,319 | $298.2398 | $4,568,735 |
| 2026-05-12 | Cordani David | -2,017 | $296.8357 | $598,718 |
| 2026-05-12 | Cordani David | -34,641 | $295.9844 | $10,253,196 |
| 2026-05-12 | Cordani David | -38,487 | $294.9798 | $11,352,888 |
| 2026-05-12 | Cordani David | -2,142 | $293.919 | $629,574 |
| 2026-05-12 | Cordani David | -7,861 | $292.8776 | $2,302,311 |
| 2026-05-12 | Cordani David | -12,315 | $291.9459 | $3,595,314 |
| 2026-05-12 | Cordani David | -13,732 | $291.0056 | $3,996,089 |
| 2026-05-12 | Cordani David | -41,099 | $290.0018 | $11,918,784 |
| 2026-05-12 | Cordani David | -13,839 | $288.8544 | $3,997,456 |
| 2026-05-12 | Cordani David | -14,292 | $287.9646 | $4,115,590 |
| 2026-05-12 | Cordani David | -3,903 | $286.832 | $1,119,505 |
| 2026-05-12 | Cordani David | +85,519 | $197.35 | $16,877,175 |
| 2026-05-12 | Cordani David | +103,595 | $149.135 | $15,449,640 |
| 2026-04-22 | Hathi Neesha | +782 | - | - |
| 2026-04-22 | Ozuah Philip | +782 | - | - |
| 2026-04-22 | Kurian George | +782 | - | - |
| 2026-04-22 | McClellan Mark B. | +782 | - | - |
| 2026-04-22 | Ross Kimberly A. | +782 | - | - |
| 2026-04-22 | Hennigan Michael J | +782 | - | - |
| 2026-04-22 | MAZZARELLA KATHLEEN M | +782 | - | - |
| 2026-04-22 | ZARCONE DONNA F | +782 | - | - |
| 2026-04-22 | WISEMAN ERIC C | +782 | - | - |
| 2026-04-22 | FOSS ERIC J | +782 | - | - |
| 2026-03-02 | Neville Everett | -1,719 | $288.91 | $496,636 |
| 2026-03-02 | Jones Nicole S | -2,307 | $288.91 | $666,515 |
| 2026-02-27 | DENNISON ANN M | +8,066 | - | - |
| 2026-02-27 | DENNISON ANN M | -409 | $287.55 | $117,608 |
| 2026-02-27 | DENNISON ANN M | +5,234 | - | - |
| 2026-02-27 | Kates Jamie G | +657 | - | - |
| 2026-02-27 | Kates Jamie G | -61 | $287.55 | $17,541 |
| 2026-02-27 | Kates Jamie G | -71 | $287.55 | $20,416 |
| 2026-02-27 | Kates Jamie G | +609 | - | - |
| 2026-02-27 | Kates Jamie G | +205 | - | - |
| 2026-02-27 | Koka Durga Prasad | +4,127 | - | - |
| 2026-02-27 | Koka Durga Prasad | -98 | $287.55 | $28,180 |
| 2026-02-27 | Koka Durga Prasad | -122 | $287.55 | $35,081 |
| 2026-02-27 | Koka Durga Prasad | +2,678 | - | - |
| 2026-02-27 | Koka Durga Prasad | +499 | - | - |
| 2026-02-27 | Evanko Brian C | +15,082 | - | - |
| 2026-02-27 | Evanko Brian C | -1,788 | $287.55 | $514,139 |
| 2026-02-27 | Evanko Brian C | -2,979 | $287.55 | $856,611 |
| 2026-02-27 | Evanko Brian C | +9,787 | - | - |
| 2026-02-27 | Evanko Brian C | +6,428 | - | - |
| 2026-02-27 | Neville Everett | +4,127 | - | - |
| 2026-02-27 | Neville Everett | -517 | $287.55 | $148,663 |
| 2026-02-27 | Neville Everett | -883 | $287.55 | $253,907 |
| 2026-02-27 | Neville Everett | +2,678 | - | - |
| 2026-02-27 | Neville Everett | +2,602 | - | - |
| 2026-02-27 | Kurian George | +104 | $289.82 | $30,141 |
| 2026-02-27 | Jones Nicole S | +8,066 | - | - |
| 2026-02-27 | Jones Nicole S | -912 | $287.55 | $262,246 |
| 2026-02-27 | Jones Nicole S | -1,826 | $287.55 | $525,066 |
| 2026-02-27 | Jones Nicole S | +5,234 | - | - |
| 2026-02-27 | Jones Nicole S | +4,133 | - | - |
| 2026-02-27 | Cordani David | +37,516 | - | - |
| 2026-02-27 | Cordani David | -4,408 | $287.55 | $1,267,520 |
| 2026-02-27 | Cordani David | -11,024 | $287.55 | $3,169,951 |
| 2026-02-27 | Cordani David | +17,389 | - | - |
| 2026-02-27 | Cordani David | +23,788 | - | - |
| 2025-11-28 | Kurian George | +108 | $108.1939 | $11,685 |
| 2025-11-03 | Cordani David | +4,134 | $241.8762 | $999,916 |
| 2025-10-06 | Evanko Brian C | -901 | - | - |
| 2025-10-06 | Evanko Brian C | +901 | $139.22 | $125,437 |
| 2025-10-03 | Evanko Brian C | -5,368 | - | - |
| 2025-10-03 | Evanko Brian C | -5,368 | $300 | $1,610,400 |
| 2025-10-03 | Evanko Brian C | +5,368 | $139.22 | $747,333 |